Gyre Therapeutics, Inc. (GYRE)
4.21
-0.31
(-6.86%)
USD |
NASDAQ |
Nov 20, 16:00
4.21
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics Price : 4.21 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 4.40 | 4.51 | 4.13 | 4.21 | 240138.0 |
| Nov 19, 2026 | 4.47 | 4.70 | 4.34 | 4.52 | 268932.0 |
| Nov 18, 2026 | 4.52 | 4.718 | 4.34 | 4.34 | 466628.0 |
| Nov 17, 2026 | 4.39 | 4.60 | 4.32 | 4.56 | 215958.0 |
| Nov 16, 2026 | 4.47 | 4.77 | 4.35 | 4.39 | 577146.0 |
| Nov 13, 2026 | 4.66 | 4.75 | 4.15 | 4.31 | 281343.0 |
| Nov 12, 2026 | 4.20 | 4.36 | 4.09 | 4.30 | 173995.0 |
| Nov 11, 2026 | 4.26 | 4.380 | 4.22 | 4.26 | 130506.0 |
| Nov 10, 2026 | 4.63 | 4.63 | 4.215 | 4.23 | 141063.0 |
| Nov 09, 2026 | 4.80 | 4.80 | 4.52 | 4.65 | 224596.0 |
| Nov 06, 2026 | 4.56 | 4.79 | 4.08 | 4.76 | 359716.0 |
| Nov 05, 2026 | 4.50 | 4.50 | 3.97 | 4.01 | 266664.0 |
| Nov 04, 2026 | 4.57 | 4.65 | 4.33 | 4.44 | 256453.0 |
| Nov 03, 2026 | 4.61 | 4.713 | 4.40 | 4.44 | 239507.0 |
| Nov 02, 2026 | 4.78 | 5.111 | 4.265 | 4.73 | 389823.0 |
| Oct 30, 2026 | 6.27 | 6.30 | 4.515 | 4.555 | 394082.0 |
| Oct 29, 2026 | 6.86 | 6.985 | 6.37 | 6.41 | 185320.0 |
| Oct 28, 2026 | 6.53 | 7.10 | 6.33 | 7.09 | 125172.0 |
| Oct 27, 2026 | 6.10 | 6.55 | 6.01 | 6.53 | 126373.0 |
| Oct 26, 2026 | 5.77 | 6.100 | 5.77 | 6.07 | 93375.00 |
| Oct 23, 2026 | 5.85 | 5.90 | 5.70 | 5.85 | 151483.0 |
| Oct 22, 2026 | 5.91 | 6.00 | 5.80 | 5.86 | 66577.00 |
| Oct 21, 2026 | 6.21 | 6.21 | 5.86 | 5.90 | 131361.0 |
| Oct 20, 2026 | 6.08 | 6.34 | 6.08 | 6.17 | 242073.0 |
| Oct 19, 2026 | 6.10 | 6.240 | 6.05 | 6.09 | 119945.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 114.62 |
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
Price Related Metrics
| PS Ratio | 3.366 |
| PEG Ratio | -0.0089 |
| Price to Book Value | 4.176 |
| Earnings Yield | -6.39% |
| Market Cap | 450.76M |
| PEGY Ratio | -0.0089 |